Computational molecular modelling as a platform for a deeper understanding of protein dynamics and rational drug design
DOI:
https://doi.org/10.4081/bse.87Keywords:
Molecular modelling, drug design neurodegenerative, protein foldingAbstract
Elucidating structural features of protein aggregation at molecular level may provide novel opportunities for overarching therapeutic approaches such as blocking common aggregation-induced cellular toxicity pathways. In this context molecular modelling stimulates further research on amyloid aggregation modulators and modelling platforms can be used to test the efficiency of potential aggregation inhibitors aimed at destabilizing/reducing the stability of the amyloidogenic proteins
Downloads
References
Downloads
Published
Issue
Section
License
Copyright (c) 2019 The Authors

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.